Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease

BACKGROUND: The association between vedolizumab (VDZ) exposure and treatment response is unclear and seems insufficiently explained by serum levels. The aim of this study was to assess the correlation between VDZ concentrations in serum and intestinal tissue and their association with mucosal inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauwels, Renske W M, Proietti, Elisa, van der Woude, Christien J, Oudijk, Lindsey, Crombag, Marie-Rose B S, Peppelenbosch, Maikel P, Grohmann, Ursula, Fuhler, Gwenny M, de Vries, Annemarie C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Basic Science Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528144/
https://www.ncbi.nlm.nih.gov/pubmed/33705545
http://dx.doi.org/10.1093/ibd/izab053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528144/
https://www.ncbi.nlm.nih.gov/pubmed/33705545
http://dx.doi.org/10.1093/ibd/izab053

Ejemplares similares